0001437749-12-003477.txt : 20120406 0001437749-12-003477.hdr.sgml : 20120406 20120405174718 ACCESSION NUMBER: 0001437749-12-003477 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20120406 DATE AS OF CHANGE: 20120405 EFFECTIVENESS DATE: 20120406 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEMACARE CORP /CA/ CENTRAL INDEX KEY: 0000801748 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 953280412 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-15223 FILM NUMBER: 12746671 BUSINESS ADDRESS: STREET 1: 15350 SHERMAN WAY STREET 2: SUITE 350 CITY: VAN NUYS STATE: CA ZIP: 91406 BUSINESS PHONE: 818-226-1968 MAIL ADDRESS: STREET 1: 15350 SHERMAN WAY STREET 2: SUITE 350 CITY: VAN NUYS STATE: CA ZIP: 91406 15-12G 1 hema_1512g-032912.htm FORM 15 hema_1512g-032912.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 15
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g)
OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
 
Commission File Number: 000-15223
 
HEMACARE CORPORATION
(Exact name of registrant as specified in its charter)
 
15350 Sherman Way, Suite 350, Van Nuys, California 91406(818) 226-1968
(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)
 
Common Stock (without par value)
Rights to purchase Preferred Stock
(Title of each class of securities covered by this Form)
 
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
 
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
 
Rule 12g-4(a)(1) x
   
Rule 12g-4(a)(2)  o
   
Rule 12h-3(b)(1)(i) x
   
Rule 12h-3(b)(1)(ii) o
   
Rule 15d-6  o
 
Approximate number of holders of record as of the certification or notice date:  two hundred forty-nine (249).
 
Pursuant to the requirements of the Securities Exchange Act of 1934, HemaCare Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
 
 
HEMACARE CORPORATION
 
  
       
Date: April 5, 2012
By:
/s/ Peter van der Wal  
   
Peter van der Wal
  
    President and Chief Executive Officer